Cosmo Pharmaceuticals reported Phase 3 results for clascoterone 5% topical solution in late 2025, showing up to 539% relative improvement in hair count versus placebo across more than 1,400 patients
Liraglutide increases IVF pregnancy rates in obese PCOS women with poor response to first-line reproductive treatments: a pilot randomized study
The computational results cited are collated in Figure S2
People with diabetes who were taking GLP-1 drugs had a low but elevated risk of an age-related eye disease that can sometimes lead to blindness, a new observational study concludes, adding to a short list of concerns about eye health in people taking the powerful medications
Business Type Exporter, Distributor, Supplier, Trading Company, Wholesaler, Dealer Employee Count 25 Establishment 1985 Working Days To GST NO 27AAHPM3187H1ZG Related Products Explore Related Categories More Products From This Seller Seller Details GST - 27AAHPM3187H1ZG Trusted Seller Mumbai, Maharashtra Accepts only Foreign inquiries Proprietor Mr
Is it safe for sensitive skin